These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2180815)

  • 1. Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection.
    Ashman RB
    Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():15-20. PubMed ID: 2180815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine candidiasis: susceptibility is associated with the induction of T cell-mediated, strain-specific autoreactivity.
    Ashman RB
    Immunol Cell Biol; 1990 Jun; 68 ( Pt 3)():179-85. PubMed ID: 2228033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance and susceptibility to infection in inbred murine strains. I. Variations in the response to thymic hormones in mice infected with Candida albicans.
    Salvin SB; Neta R
    Cell Immunol; 1983 Jan; 75(1):160-72. PubMed ID: 6218893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to Candida albicans in genetically distinct mice.
    Hector RF; Domer JE; Carrow EW
    Infect Immun; 1982 Dec; 38(3):1020-8. PubMed ID: 6759403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigens and immune responses in Candida albicans infection.
    Ashman RB; Papadimitriou JM; Ott AK; Warmington JR
    Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():1-13. PubMed ID: 2180814
    [No Abstract]   [Full Text] [Related]  

  • 6. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.
    Mizutani S; Endo M; Ino-Ue T; Kurasawa M; Uno Y; Saito H; Onogi K; Kato I; Takesako K
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2653-8. PubMed ID: 10991839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.
    Moser SA; Domer JE; Mather FJ
    Infect Immun; 1980 Jan; 27(1):140-9. PubMed ID: 6987165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.
    Garner RE; Kuruganti U; Czarniecki CW; Chiu HH; Domer JE
    Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolates of Candida albicans that differ in virulence for mice elicit strain-specific antibody-mediated protective responses.
    Hu Y; Farah CS; Ashman RB
    Microbes Infect; 2006 Mar; 8(3):612-20. PubMed ID: 16503182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune responses to systemic Candida albicans infection in inbred mouse strains.
    Costantino PJ; Gare NF; Warmington JR
    Immunol Cell Biol; 1995 Apr; 73(2):125-33. PubMed ID: 7797232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclophosphamide on murine candidiasis.
    Moser SA; Domer JE
    Infect Immun; 1980 Feb; 27(2):376-86. PubMed ID: 6991413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early T cell unresponsiveness in mice with candidiasis and reversal by IL-2: effect on T helper cell development.
    Spaccapelo R; Del Sero G; Mosci P; Bistoni F; Romani L
    J Immunol; 1997 Mar; 158(5):2294-302. PubMed ID: 9036977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain differences in the severity of lesions in murine systemic candidiasis correlate with the production of functional gamma interferon by Candida-activated lymphocytes in vitro.
    Ashman RB; Bolitho EM
    Lymphokine Cytokine Res; 1993 Dec; 12(6):471-6. PubMed ID: 8123764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans.
    Wanasaengsakul S; Ashman RB
    Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.
    Garner RE; Domer JE
    Infect Immun; 1994 Feb; 62(2):738-41. PubMed ID: 7507901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Delayed hypersensitivity to Candida albicans].
    Frolova EV; Prokrovskaia OL; Karaev ZO
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):103-7. PubMed ID: 2238997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodeficient CBA/N mice respond effectively to Candida albicans.
    Carrow EW; Hector RF; Domer JE
    Clin Immunol Immunopathol; 1984 Dec; 33(3):371-80. PubMed ID: 6388927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.